| Dr Charla Joseph, AUD | |
|
1855 Plumas St, Suite 5, Reno, NV 89509-3360 | |
| (775) 825-6006 | |
| Not Available |
| Full Name | Dr Charla Joseph |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 1855 Plumas St, Reno, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629102942 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 002048-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charla Joseph, AUD 1855 Plumas St, Suite 5, Reno, NV 89509-3360 Ph: (775) 825-6006 | Dr Charla Joseph, AUD 1855 Plumas St, Suite 5, Reno, NV 89509-3360 Ph: (775) 825-6006 |
News Archive
After two years of double-digit price hikes, the average premium for individual health coverage on the federal health law's insurance marketplace will drop by 1.5 percent for 2019, the Trump administration said Thursday.
Yadira Alatriste, researcher at the Autonomous Metropolitan University of Mexico designed a remote medical care system that supports the rehabilitation of people with spasticity, an alteration of the nervous system related to increased tone muscle making motor skills difficult or impossible for those affected.
New evidence has emerged from studies in mice that short telomeres or "caps" at the ends of chromosomes may predispose people to age-related diabetes, according to Johns Hopkins scientists.
Medical Marijuana, Inc. endorsed today the unprecedented act of President Obama signing into federal law the removal of restrictions on the use of medical marijuana in the nation's capitol, which underscores MJNA's foresight in becoming the first US public company to emerge, providing solutions to this revolutionary growth industry.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced receipt of a $750,000 milestone payment under its collaboration with AVEO Pharmaceuticals, Inc.. The milestone payment resulted from AVEO's recent initiation of a Phase 2 clinical trial to evaluate its AV-299 antibody for the treatment of non-small cell lung cancer. AV-299 is a humanized antibody to hepatocyte growth factor (HGF).
› Verified 7 days ago
Dr. Michael Anthony Hodes, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 501 Hammill Ln, Reno, NV 89511 Phone: 775-682-4000 Fax: 775-682-4003 | |
Dr. Kayla Kaikelii Navarro, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 900 Ryland St, Reno, NV 89502 Phone: 775-329-7017 | |
Dr. Kasey O'hara, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2667 Enterprise Rd, Reno, NV 89512 Phone: 775-688-1341 Fax: 775-688-2984 | |
Dr. Angela Hayden, AUD, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 343 Elm St Ste 204, Reno, NV 89503 Phone: 775-329-7017 Fax: 775-323-0749 | |
Reno Hearing Center Audiologist Medicare: Medicare Enrolled Practice Location: 1855 Plumas St, Suite 5, Reno, NV 89509 Phone: 775-825-6006 Fax: 775-825-6188 | |
Dr. Chelsea Cathleen Peterson, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 6630 S Mccarran Blvd Ste B16, Reno, NV 89509 Phone: 775-323-5566 | |
Khloe Layo Kaufman, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 900 Ryland St, Reno, NV 89502 Phone: 775-329-7017 Fax: 775-323-0749 |